"Revolutionary Therapy Rapidly Shrinks Deadly Brain Tumors in Early Trials"
TL;DR
A new immunotherapeutic approach using CAR T-cell therapy has shown promising results in treating glioblastoma, a deadly form of brain cancer. In a small clinical trial, one patient experienced a significant reduction in tumor size within days of receiving the treatment, while others saw mixed outcomes. The therapy targets a mutated protein prevalent in glioblastomas, and researchers are optimistic about its potential as a treatment, although long-term effectiveness is still unknown. Further study and clinical trials are needed to determine the therapy's efficacy in treating this incurable disease.
Topics:healthmedical-breakthrough#cancer#car-t-cell-therapy#glioblastoma#immunotherapy#medical-breakthrough#medical-research
- Breakthrough Therapy Obliterates Deadly Brain Tumor in Days ScienceAlert
- ‘Nothing else that has had this effect’: New treatment shrinks brain tumors in small clinical trial at Mass. General The Boston Globe
- Early clinical trial results show 'dramatic and rapid' regression of glioblastoma after next generation CAR-T therapy Medical Xpress
- Living drugs that reprogram patients’ immune cells show early promise against hard-to-treat brain tumors CNN
- In two early trials, blood cancer treatment appears promising for deadly brain tumor NBC News
Want the full story? Read the original reporting
Read on ScienceAlert